Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Objective: To study differences in treatment for men and women with ischaemic heart disease by using standards defined in England's national service framework for coronary artery disease. Design: Cross sectional survey using routinely collected data. Setting: 18 practices in 18 primary care groups in Trent Region. Subjects: 5891 men and women aged over 35 years with a diagnosis of ischaemic heart disease or prescription for nitrates recorded on computer. Main outcome measure: Difference in the proportion of men and women with ischaemic heart disease and taking lipid lowering treatment. Results: Women were less likely than men to have a recording of body mass index (79% (2197/2783) v 82% (2552/3102), P = 0.002), smoking (86% (2386) v 89% (2779), P < 0.0001), and blood pressure (95% (2643) v 96% (2986), P = 0.04). Women were also less likely to have a recording of fasting cholesterol concentration (35% (968) v 50% (1550), P < 0.0001) but were more likely to be obese (25% (558/2197) v 20% (514/2552), P < 0.0001) and have their most recently recorded blood pressure value over the recommended 140/85 mm Hg (60% (1598/2643) v 52% (1553/2986), P < 0.0001). Although a higher proportion of women had a raised serum cholesterol concentration (77% (749/968) v 67% (1043/1550), P < 0.0001), men were more likely to take aspirin (76% (2358) v 71% (1979), P < 0.0001), have a recorded diagnosis of hyperlipidaemia (13% (418) v 10% (274), P < 0.0001), and be prescribed lipid lowering drugs (31% (973) v 21% (596), P < 0.0001). These differences remained despite adjustments for the practice where the patient is registered, age, smoking stares, obesity, diabetes, and hypertension. Conclusion: The results suggest a systematic bias towards men compared with women in terms of secondary prevention of ischaemic heart disease.

Type

Journal article

Journal

British Medical Journal

Publication Date

07/04/2001

Volume

322

Pages

832 - 834